AstraZeneca will pay $520 million to settle claims it improperly marketed its anti-psychotic drug Seroquel, the Department of Justice said Tuesday. Under the settlement, the federal government will get $301.9 million from the civil settlement, and the state Medicaid programs will get up to $218.1 million.
AstraZeneca was charged with promoting Seroquel for such unapproved uses as anxiety, attention deficit hyperactivity disorder, and bipolar maintenance, and for unapproved populations such as children and the elderly, according to the Justice Department.
No comments:
Post a Comment